Anti-PD-1 immunotherapy with dose-adjusted ultra-hypofractionated re-irradiation in patients with locoregionally recurrent head and neck cancer

INTRODUCTION: Patients with recurrent inoperable squamous-cell head-neck cancer (HNSCC) after chemo-radiotherapy have an ominous prognosis. Re-irradiation can be applied with some efficacy and high toxicity rates. Anti-PD-1 immunotherapy is effective in 25% of patients. Immunogenic death produced by...

Descripción completa

Detalles Bibliográficos
Autores principales: Koukourakis, Ioannis M., Giakzidis, Axiotis G., Koukourakis, Michael I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462536/
https://www.ncbi.nlm.nih.gov/pubmed/37059932
http://dx.doi.org/10.1007/s12094-023-03172-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462536/
https://www.ncbi.nlm.nih.gov/pubmed/37059932
http://dx.doi.org/10.1007/s12094-023-03172-y

Ejemplares similares